Form 4: Tenon Medical CTO Reports Stock Transaction
Insider Transaction (Form 4)
Richard Ginn, Chief Technology Officer and a Director of Tenon Medical, Inc., reported multiple transactions in common stock on July 31, 2026.
Summary
- Option exercise/conversion: acquired 126,577 Common Stock on July 31, 2026; holds 212,166 after (Direct).
- Tax/exercise-price withholding: disposed of 44,809 Common Stock at $0.20 ($8,872) on August 3, 2026; holds 167,357 after (Direct).
- Option exercise/conversion: disposed of 126,577 Restricted Stock Units on July 31, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Richard Ginn — Director, Officer (Chief Technology Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-31 | Option exercise/conversion | Common Stock | 126,577 | — | — | 212,166 |
| 2026-08-03 | Tax/exercise-price withholding | Common Stock | 44,809 | $0 | $8.9K | 167,357 |
| 2026-07-31 | Option exercise/conversion | Restricted Stock Units | 126,577 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-31 | Option exercise/conversion (126,577 shares) |
| 2026-08-03 | Tax/exercise-price withholding (44,809 shares) |
| 2026-07-31 | Option exercise/conversion (126,577 shares) |
Keywords
insider transaction, Form 4, TNON, Tenon Medical, Inc., neutral, Richard Ginn
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.